Skip to main content

MPT ALERT: Bragar Eagel & Squire, P.C. is Investigating Medical Properties Trust, Inc. on Behalf of MPT Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Medical Properties Trust, Inc. (“MPT” or the “Company”) (NYSE: MPW) on behalf of MPT stockholders. Our investigation concerns whether MPT has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

On February 23, 2023, MPT announced its fourth quarter and full year 2022 financial results. Among other items, the Company disclosed an impairment of approximately $171 million on four properties leased to Prospect Medical Holdings and announced a plan to write off about $112 million in unbilled rent from the same client.

On this news, MPT’s stock price fell $1.06 per share, or 8.69%, to close at $11.14 per share on February 23, 2023.

If you purchased or otherwise acquired MPT shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.